1Goldfarb AH, McIntosh MK, Boyer BT. Vitamin E attenuates myocardial oxidative stress induced by DHEA in rested and exercised rats[J]. Appl Physiol,1996;80(2):486-90.
2Aarnisalo AA,Aalto-Setala K,Holthofer H ,et al . Puromycin-induced lipid peroxidation in the cochlea of ApoE knockout mice[J].Acta Otolaryngol,2000;543: 102-4.
3Russell JC,Graham SE,Amy RM,et al . Cardioprotective effect of probucol in the atherosclerosis-prone JCR:LA-cp rat[J]. Eur J Pharmacol,1998;350(2-3): 203-10.
5Kunsch C, Luchoomun J, Grey JY, et al . Selective inhibition of endothelial and monocyte redox-sensitive genes by AGI-1067: a novel antioxidant and anti-inflammatory agent[J].Pharma Exp Ther,2004; 308(3): 820 -9.
6Sundell CL, Somers PK, Meng CQ, et al . AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agent[J].Pharma Exp Ther,2003; 305: 1116 -23.
7Sarataho EP,Salonen JT,Nyyssonen K, et al . Long-term effects of vitamin E, vitamin C, and combined supplementation on urinary 7-Hydro-8-Oxo-2'-deoxyguanosine, serum cholesterol oxidation products, and oxidation resistance of lipids in nondepleted men arteriosclerosis[J].Throm Vasc Biol,2000; 20:2087-93.
8The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high-risk patients[J].N Engl J Med, 2003;342:154-60.
9Stephens NG, Parsons A, Schofield PM, et al . Randomised controlled trial of vitamin E in patients with coronary disease: cambridge heart antioxidant study[J].Lancet,1996; 347:781-6.
10Tardif JC, Cote G, Lesperance J, et al . Probucol and multivitamins in the prevention of restenosis after coronary angioplasty[J].N Engl J Med, 1997; 337(6):365-72.
二级参考文献10
1[1]Ambrose JA, Martinez EE. A new paradigm for plaque stabilization. Circulation, 2002, 105 (16): 2 000-004
2[2]Brasen JH, Harsch M, Niendorf A. Survival and cardiovascular pathology of hetero-zygous watanabe heritable hyperlipidaemic rabbits treated with pravastatin and probucol on a low-cholesterol(0.03%)-enriched diet. Virchows Arch, 1998, 432 (6): 557-562
3[3]Brasen JH, Harsch M, Niendorf A. Probucol inhibits not only the progression of atherosclerotic disease, but causes a different composition of atherosclerotic lesions in WHHL-rabbits. Virchows Arch, 1995, 426 (2):179-188
4[4]Xu XP, Meisel SR, Ong JM. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human moncyte-derived macrophages. Circulation, 1999, 99: 993-998
5[6]Crisby M, Nordin-Fredriksson G, Shah PK. Pravastatin treatment increases collagen content and decreases lipid content, inflammation,metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation, 2001, 103: 926-933
6[7]Libby P. What have we learned about the biology of atherosclerosis? The role of inflammation. Am J Cardiol, 2001, 88: 3J-6J
7[8]Loftus IM, Naylor AR, Goodall S. Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke, 2000, 31 (1): 40-47
